Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAscent Resources Regulatory News (AST)

Share Price Information for Ascent Resources (AST)

Share Price is delayed by 15 minutes
Get Live Data
0.50    0.00 (0.00%)
Bid:
0.45
Ask:
0.55
Spread: 0.10 (22.222%)
Market Cap: £4.16m
AST Live PriceLast checked at - London Stock Exchange

Intraday Ascent Resources Share Chart

Option Agreement for exploitation in Utah

26 Nov 2025 07:00

RNS Number : 9724I
Ascent Resources PLC
26 November 2025
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY IN THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. ANY FAILURE TO COMPLY WITH THESE RESTRICTIONS MAY CONSTITUTE A VIOLATION OF APPLICABLE SECURITIES LAWS. PLEASE SEE THE SECTION ENTITLED "IMPORTANT INFORMATION" TOWARDS THE END OF THIS ANNOUNCEMENT.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION (EU) 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EU (WITHDRAWAL) ACT 2018 ("MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

26 November 2025

Ascent Resources plc

("Ascent" or the "Company")

Option Agreement for the exploitation of critical mineral-rich brines in Utah

Ascent Resources Plc (LON: AST), the onshore US focused oil and gas company, is pleased to announce that it has, together with its partner American Helium, LLC ("AH"), entered into an option agreement ("Option Agreement") with Neometals Ltd (ASX: NMT) and its partner Omaha Value, LLC (together "NMT/OMA").

The agreement grants NMT/OMA a 60-day exclusive option (extendable by mutual consent) to negotiate a definitive access and use licence over Ascent and AH's portfolio of existing oil and gas wells and leases in the Paradox Basin, Utah, for the purpose of exploring and potentially extracting lithium and potash from critical mineral-rich brines.

Key benefits of the proposed arrangement

· Represents a new monetisation pathway for Ascent's large Paradox Basin acreage position with no upfront drilling or development cost to the Company;

· Provides access to deep, artesian brines previously intersected during historic oil, gas and helium exploration;

· Leverages the critical mineral status of lithium and potash, which may qualify for accelerated permitting and potential US federal funding;

· Utilises existing wellbores and infrastructure, significantly reducing time and cost versus drilling new wells.

Financial terms of the Option Agreement

The following terms are gross and corresponding benefits to be shared between Ascent and AH pro-rata of their respective interests in the portfolio, i.e. Ascent 49% and American Helium 51%.

· Exclusivity fee: US$50,000 (payable within five business days);

· Option exercise fee (if exercised): US$50,000;

· Permitting fee: US$1.9 million payable on grant of relevant mineral leases, and pro-rated if fewer wells are available;

· Annual licence fee: US$200,000 (payable in arrears);

· Royalty on future brine production: 2.5% of gross revenue, increasing to 3.5% if commercial extraction has not commenced within five years of mineral lease grant.

Strategic rationale

This transaction highlights the embedded multi-commodity potential of Ascent's Utah and Colorado acreage across hydrocarbons, helium, CO2 sequestration and now critical mineral-rich brines. By partnering with an experienced lithium-focused developer in Neometals and a well-resourced local partner in Omaha Value, Ascent can unlock additional value from its existing asset base at minimal cost and dilution to shareholders.

Next steps

NMT/OMA will now undertake technical, legal and commercial due diligence during the 60-day exclusivity period. The Company will update the market on material developments as appropriate.

There is no certainty that the option will be exercised or that binding definitive agreements will be entered into.

 

Enquiries

Ascent Resources plc

Jean-Michel Doublet

info3@ascentresources.co.uk

 

Zeus, Nominated Adviser & Broker

James Joyce / James Bavister

0203 829 5000

Novum Securities, Joint Broker

Jon Belliss / Colin Rowbury

0207 399 9400

 

Fortified Securities, Joint-Broker

Guy Wheatley

0203 411 7773

Shard Capital Partners LLP, Joint-Broker

Damon Heath

0207 186 9952

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRUVVNRVOUAUAA
Date   Source Headline
19th May 20267:00 amRNSRiverfort Amendment, Share Settlements & TVR
6th May 20267:00 amRNSUpdate on Slovenia ECT Claim
24th Apr 20267:00 amRNSJORC Exploration Target Defined by Neometals
27th Mar 20267:00 amRNSSpecial Bonus Award - Related Party Transaction
24th Mar 20267:00 amRNSUpdate on Slovenia ECT Claim
20th Mar 20267:00 amRNSExclusive Licence with Neometals
16th Mar 20269:37 amRNSGrant of Share Options and PDMR Notification
16th Mar 20269:37 amRNSGrant of Share Options and PDMR Notification
11th Mar 20267:00 amRNSUpdate on Slovenia Disputes
28th Jan 20262:20 pmRNSGrant of Share Options / PDMR Notification
14th Jan 20267:00 amRNSUpdate on Energy Charter Treaty Claim
26th Nov 20257:00 amRNSOption Agreement for exploitation in Utah
7th Oct 20257:00 amRNSUpdate on disputes out of Slovenian Joint Venture
29th Sep 20257:00 amRNSInterim results for the period ended 30 June 2025
23rd Sep 20257:00 amRNSUpdate on Energy Charter Treaty Claim
30th Jul 20257:00 amRNSBoard Changes
23rd Jul 20253:56 pmRNSHolding(s) in Company
16th Jul 20257:00 amRNSHolding(s) in Company
15th Jul 20257:24 amRNSOperations Update and Amendment to the PSAs
9th Jul 20257:00 amRNSAppointment of CEO
3rd Jul 20257:16 amRNSSuccessful Slovenia Domestic Arbitration Outcome
27th Jun 20253:11 pmRNSResults of Annual General Meeting
27th Jun 20257:00 amRNSUpdate on Utah Operations
20th Jun 20257:00 amRNSInitiation of work-program on ARB Energy
13th Jun 20252:11 pmRNSShares for Fees, Warrants, Options and PDMR
11th Jun 20257:00 amRNSHolding(s) in Company
9th Jun 20253:05 pmRNSHolding(s) in Company
2nd Jun 20257:00 amRNSFinal Results and Notice of AGM
22nd May 20252:05 pmRNSAcquisitions, Fundraising and Debt Reprofiling
21st May 20252:48 pmRNSHolding(s) in Company
21st May 20252:46 pmRNSHolding(s) in Company
17th Apr 20257:00 amRNSECT Hearing Concluded
20th Feb 20253:18 pmRNSResult of Meeting
11th Feb 20255:26 pmRNSHolding(s) in Company
11th Feb 20251:12 pmRNSHolding(s) in Company
5th Feb 20257:00 amRNSNotice of Record Date, GM & posting of Circular
28th Jan 20255:26 pmRNSIssue of Equity & Total Voting Rights
27th Jan 20257:00 amRNS-RPublication of Research
22nd Jan 20254:28 pmRNSHolding(s) in Company
17th Jan 202512:48 pmRNSHolding(s) in Company
15th Jan 20252:05 pmRNSHolding(s) in Company
10th Jan 20257:00 amRNSAdmission Date & Total Voting Rights
30th Dec 20242:58 pmRNSHolding(s) in Company
24th Dec 20247:00 amRNS-RUpdated Corporate Presentation
24th Dec 20247:00 amRNSDirector/PDMR Shareholding
20th Dec 20247:00 amRNSInvestment in US Gas, Oil and Helium Portfolio
11th Dec 20247:00 amRNSUpdate on former JV Partner’s Insolvency Process
9th Dec 20247:00 amRNSNew Joint Venture & Board Changes
29th Oct 20243:53 pmRNSHolding(s) in Company
23rd Oct 20241:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.